NW Bio is a Maryland-based biotechnology company that develops and commercializes immune therapies for the treatment of solid tumor cancers.
Business Model:
Revenue: $1.1M
Employees: 11-50
Address: 4800 Montgomery Lane
City: Bethesda
State: MD
Zip: 20814
Country: US
NW Bio is a Maryland-based biotechnology company that develops and commercializes immune therapies for the treatment of solid tumor cancers.
Contact Phone:
+12404979024
Contact Email:
Listed Exchange:
OTCMKTS
IPO Date:
12/19/2016
Ticker Symbol:
NWBO
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 8/2020 | Debt | $5M | 11/2021 | Post-IPO Debt | $15M | 10/2014 | Post-IPO Equity | $11.5M | 11/2018 | Post-IPO Equity | $5M | 8/2020 | Convertible Note | $1M | 5/2020 | Debt | $350k |
U.S. Small Business Administration. |
8/2020 | Post-IPO Debt | $5.5M | 12/2010 | Venture Round | $395k | 4/2015 | Post-IPO Equity | 1 | $40M |
Woodford Investment Management Woodford Investment Management |
11/2014 | Post-IPO Equity | 1 | $35M |
Woodford Investment Management Woodford Investment Management Woodford Investment Management Woodford Investment Management |
12/2017 | Post-IPO Equity | $12M | 8/2020 | Post-IPO Equity | $8M | 11/2013 | Post-IPO Equity | $27M | 3/2016 | Post-IPO Debt | $10M |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|